Acoustic cardiography S3 detection use in problematic subgroups and B-type natriuretic peptide "gray zone": Secondary results from the Heart failure and Audicor technology for Rapid Diagnosis and Initial Treatment Multinational Investigation

Alan S. Maisel, W. Frank Peacock, Kevin S. Shah, Paul Clopton, Deborah Diercks, Brian Hiestand, Michael C. Kontos, Christian Mueller, Richard Nowak, Wen Jone Chen, Sean P. Collins

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Background: Dyspneic emergency department (ED) patients present a diagnostic dilemma. The S3, although highly specific for acute heart failure (AHF) and predicting death and readmission, is often difficult to auscultate. The HEart failure and Audicor technology for Rapid Diagnosis and Initial Treatment (HEARD-IT) multinational trial evaluated the S3 via acoustic cardiography (Audicor). Our goal in this secondary analysis was to determine if the strength of the S3 can provide diagnostic/prognostic information in problematic heart failure subgroups. Methods: Dyspneic ED patients older than 40 years and not on dialysis were prospectively enrolled. A gold standard AHF diagnosis was determined by 2 cardiologists blinded to acoustic cardiography results. The S3 strength parameter was delineated on a scale of 0 to 10. This secondary analysis of subgroups from the HEARD-IT database used univariate/multivariate regression to determine the diagnostic/prognostic ability of the S3 strength. Results: In the 995 patients enrolled, S3 strength was a significant prognosticator in univariate analysis for adverse events but not in a multivariable model. In patients with "gray zone" B-type natriuretic peptide (BNP) levels (100-499 pg/mL), acoustic cardiography increased diagnostic accuracy of AHF from 47% to 69%. Acoustic cardiography improved S3 detection sensitivity in obese patients when compared to auscultation. Conclusion: The strength of the S3 gallop provides rapid results that assist with identification of AHF in selected populations. S3 detection complements the use of BNP in the gray zone, and its diagnostic/prognostic ability is largely unaffected by body mass index and renal function. S3 strength shows promise as a diagnostic and prognostic tool in problematic HF subgroups.

Original languageEnglish (US)
Pages (from-to)924-931
Number of pages8
JournalAmerican Journal of Emergency Medicine
Volume29
Issue number8
DOIs
StatePublished - Oct 2011

Fingerprint

Brain Natriuretic Peptide
Acoustics
Heart Failure
Technology
Therapeutics
Hospital Emergency Service
Auscultation
Dialysis
Body Mass Index
Databases
Kidney
Population

ASJC Scopus subject areas

  • Emergency Medicine

Cite this

Acoustic cardiography S3 detection use in problematic subgroups and B-type natriuretic peptide "gray zone" : Secondary results from the Heart failure and Audicor technology for Rapid Diagnosis and Initial Treatment Multinational Investigation. / Maisel, Alan S.; Peacock, W. Frank; Shah, Kevin S.; Clopton, Paul; Diercks, Deborah; Hiestand, Brian; Kontos, Michael C.; Mueller, Christian; Nowak, Richard; Chen, Wen Jone; Collins, Sean P.

In: American Journal of Emergency Medicine, Vol. 29, No. 8, 10.2011, p. 924-931.

Research output: Contribution to journalArticle

Maisel, Alan S. ; Peacock, W. Frank ; Shah, Kevin S. ; Clopton, Paul ; Diercks, Deborah ; Hiestand, Brian ; Kontos, Michael C. ; Mueller, Christian ; Nowak, Richard ; Chen, Wen Jone ; Collins, Sean P. / Acoustic cardiography S3 detection use in problematic subgroups and B-type natriuretic peptide "gray zone" : Secondary results from the Heart failure and Audicor technology for Rapid Diagnosis and Initial Treatment Multinational Investigation. In: American Journal of Emergency Medicine. 2011 ; Vol. 29, No. 8. pp. 924-931.
@article{4d5895252aae4e18a8ebf81edd498af4,
title = "Acoustic cardiography S3 detection use in problematic subgroups and B-type natriuretic peptide {"}gray zone{"}: Secondary results from the Heart failure and Audicor technology for Rapid Diagnosis and Initial Treatment Multinational Investigation",
abstract = "Background: Dyspneic emergency department (ED) patients present a diagnostic dilemma. The S3, although highly specific for acute heart failure (AHF) and predicting death and readmission, is often difficult to auscultate. The HEart failure and Audicor technology for Rapid Diagnosis and Initial Treatment (HEARD-IT) multinational trial evaluated the S3 via acoustic cardiography (Audicor). Our goal in this secondary analysis was to determine if the strength of the S3 can provide diagnostic/prognostic information in problematic heart failure subgroups. Methods: Dyspneic ED patients older than 40 years and not on dialysis were prospectively enrolled. A gold standard AHF diagnosis was determined by 2 cardiologists blinded to acoustic cardiography results. The S3 strength parameter was delineated on a scale of 0 to 10. This secondary analysis of subgroups from the HEARD-IT database used univariate/multivariate regression to determine the diagnostic/prognostic ability of the S3 strength. Results: In the 995 patients enrolled, S3 strength was a significant prognosticator in univariate analysis for adverse events but not in a multivariable model. In patients with {"}gray zone{"} B-type natriuretic peptide (BNP) levels (100-499 pg/mL), acoustic cardiography increased diagnostic accuracy of AHF from 47{\%} to 69{\%}. Acoustic cardiography improved S3 detection sensitivity in obese patients when compared to auscultation. Conclusion: The strength of the S3 gallop provides rapid results that assist with identification of AHF in selected populations. S3 detection complements the use of BNP in the gray zone, and its diagnostic/prognostic ability is largely unaffected by body mass index and renal function. S3 strength shows promise as a diagnostic and prognostic tool in problematic HF subgroups.",
author = "Maisel, {Alan S.} and Peacock, {W. Frank} and Shah, {Kevin S.} and Paul Clopton and Deborah Diercks and Brian Hiestand and Kontos, {Michael C.} and Christian Mueller and Richard Nowak and Chen, {Wen Jone} and Collins, {Sean P.}",
year = "2011",
month = "10",
doi = "10.1016/j.ajem.2010.03.032",
language = "English (US)",
volume = "29",
pages = "924--931",
journal = "American Journal of Emergency Medicine",
issn = "0735-6757",
publisher = "W.B. Saunders Ltd",
number = "8",

}

TY - JOUR

T1 - Acoustic cardiography S3 detection use in problematic subgroups and B-type natriuretic peptide "gray zone"

T2 - Secondary results from the Heart failure and Audicor technology for Rapid Diagnosis and Initial Treatment Multinational Investigation

AU - Maisel, Alan S.

AU - Peacock, W. Frank

AU - Shah, Kevin S.

AU - Clopton, Paul

AU - Diercks, Deborah

AU - Hiestand, Brian

AU - Kontos, Michael C.

AU - Mueller, Christian

AU - Nowak, Richard

AU - Chen, Wen Jone

AU - Collins, Sean P.

PY - 2011/10

Y1 - 2011/10

N2 - Background: Dyspneic emergency department (ED) patients present a diagnostic dilemma. The S3, although highly specific for acute heart failure (AHF) and predicting death and readmission, is often difficult to auscultate. The HEart failure and Audicor technology for Rapid Diagnosis and Initial Treatment (HEARD-IT) multinational trial evaluated the S3 via acoustic cardiography (Audicor). Our goal in this secondary analysis was to determine if the strength of the S3 can provide diagnostic/prognostic information in problematic heart failure subgroups. Methods: Dyspneic ED patients older than 40 years and not on dialysis were prospectively enrolled. A gold standard AHF diagnosis was determined by 2 cardiologists blinded to acoustic cardiography results. The S3 strength parameter was delineated on a scale of 0 to 10. This secondary analysis of subgroups from the HEARD-IT database used univariate/multivariate regression to determine the diagnostic/prognostic ability of the S3 strength. Results: In the 995 patients enrolled, S3 strength was a significant prognosticator in univariate analysis for adverse events but not in a multivariable model. In patients with "gray zone" B-type natriuretic peptide (BNP) levels (100-499 pg/mL), acoustic cardiography increased diagnostic accuracy of AHF from 47% to 69%. Acoustic cardiography improved S3 detection sensitivity in obese patients when compared to auscultation. Conclusion: The strength of the S3 gallop provides rapid results that assist with identification of AHF in selected populations. S3 detection complements the use of BNP in the gray zone, and its diagnostic/prognostic ability is largely unaffected by body mass index and renal function. S3 strength shows promise as a diagnostic and prognostic tool in problematic HF subgroups.

AB - Background: Dyspneic emergency department (ED) patients present a diagnostic dilemma. The S3, although highly specific for acute heart failure (AHF) and predicting death and readmission, is often difficult to auscultate. The HEart failure and Audicor technology for Rapid Diagnosis and Initial Treatment (HEARD-IT) multinational trial evaluated the S3 via acoustic cardiography (Audicor). Our goal in this secondary analysis was to determine if the strength of the S3 can provide diagnostic/prognostic information in problematic heart failure subgroups. Methods: Dyspneic ED patients older than 40 years and not on dialysis were prospectively enrolled. A gold standard AHF diagnosis was determined by 2 cardiologists blinded to acoustic cardiography results. The S3 strength parameter was delineated on a scale of 0 to 10. This secondary analysis of subgroups from the HEARD-IT database used univariate/multivariate regression to determine the diagnostic/prognostic ability of the S3 strength. Results: In the 995 patients enrolled, S3 strength was a significant prognosticator in univariate analysis for adverse events but not in a multivariable model. In patients with "gray zone" B-type natriuretic peptide (BNP) levels (100-499 pg/mL), acoustic cardiography increased diagnostic accuracy of AHF from 47% to 69%. Acoustic cardiography improved S3 detection sensitivity in obese patients when compared to auscultation. Conclusion: The strength of the S3 gallop provides rapid results that assist with identification of AHF in selected populations. S3 detection complements the use of BNP in the gray zone, and its diagnostic/prognostic ability is largely unaffected by body mass index and renal function. S3 strength shows promise as a diagnostic and prognostic tool in problematic HF subgroups.

UR - http://www.scopus.com/inward/record.url?scp=80053581931&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053581931&partnerID=8YFLogxK

U2 - 10.1016/j.ajem.2010.03.032

DO - 10.1016/j.ajem.2010.03.032

M3 - Article

C2 - 20627217

AN - SCOPUS:80053581931

VL - 29

SP - 924

EP - 931

JO - American Journal of Emergency Medicine

JF - American Journal of Emergency Medicine

SN - 0735-6757

IS - 8

ER -